Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zagociguat in MELAS (PRIZM)
NCT06402123Phase 2Completed
- Sponsor
- Tisento Therapeutics
- Start
- Sep 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of zagociguat in Mitochondrial encephalomyopathy (ME), sponsored by Tisento Therapeutics. Started Sep 2024; status: completed.
02
Drugs
zagociguat
03
Conditions
Mitochondrial encephalomyopathy (ME)
Beyond the preview
Go deeper on NCT06402123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402123.